{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:30:30Z","timestamp":1669919430646},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T00:00:00Z","timestamp":1408838400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Anesth"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00540-014-1903-x","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T03:31:57Z","timestamp":1408764717000},"page":"186-190","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Direct effects of Rho-kinase inhibitor on pial microvessels in rabbits"],"prefix":"10.1007","volume":"29","author":[{"given":"Masakazu","family":"Kotoda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadahiko","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Shintani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Matsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,24]]},"reference":[{"key":"1903_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.273.5272.245","volume":"3","author":"K Kimura","year":"1996","unstructured":"Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Fenf J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science. 1996;3:245\u20138.","journal-title":"Science"},{"key":"1903_CR2","doi-asserted-by":"crossref","first-page":"12257","DOI":"10.1074\/jbc.272.19.12257","volume":"272","author":"Y Kureishi","year":"1997","unstructured":"Kureishi Y, Kobayashi S, Amano M, Amano M, Kimura K, Kanaide H, Nakano T, Kaibuchi K, Ito M. Rho-associated kinase directly induces smooth muscle contraction through myosin light chain phosphorylation. J Biol Chem. 1997;272:12257\u201360.","journal-title":"J Biol Chem"},{"key":"1903_CR3","doi-asserted-by":"crossref","first-page":"20246","DOI":"10.1074\/jbc.271.34.20246","volume":"271","author":"M Amano","year":"1996","unstructured":"Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem. 1996;271:20246\u20139.","journal-title":"J Biol Chem"},{"key":"1903_CR4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1002\/j.1460-2075.1996.tb00574.x","volume":"15","author":"T Matsui","year":"1996","unstructured":"Matsui T, Amano M, Yamamoto T, Chihara K, Nakafuku M, Ito M, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 1996;15:2208\u201316.","journal-title":"EMBO J"},{"key":"1903_CR5","doi-asserted-by":"crossref","first-page":"29051","DOI":"10.1074\/jbc.270.42.25107","volume":"270","author":"T Leung","year":"1995","unstructured":"Leung T, Manser E, Tan L, Lim L. A novel serine\/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes. J Biol Chem. 1995;270:29051\u20134.","journal-title":"J Biol Chem"},{"key":"1903_CR6","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1002\/j.1460-2075.1996.tb00539.x","volume":"15","author":"T Ishizaki","year":"1996","unstructured":"Ishizaki T, Maekawa M, Fujisawa K, Okawa K, Iwamatsu A, Fujita A, Watanabe N, Saito Y, Kakizuka A, Morii N, Narumiya S. The small GTP-binding protein Rho binds to and activates a 160\u00a0kDa Ser\/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J. 1996;15:1885\u201393.","journal-title":"EMBO J"},{"key":"1903_CR7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2013.01.011","volume":"167","author":"V Gupta","year":"2013","unstructured":"Gupta V, Gupta N, Shaik IH, Mehvar R, McMurtry IF, Oka M, Nozik-Grayck E, Komatsu M, Ahsan F. Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. J Control Release. 2013;167:189\u201399.","journal-title":"J Control Release"},{"key":"1903_CR8","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1540-8191.2009.00888.x","volume":"24","author":"X Kun","year":"2009","unstructured":"Kun X, Lefeng W, Rongjing D, Xincun Y. RhoA\/ROK pathway related to the mechanism of higher susceptibility to spasm in RA than IMA. J Card Surg. 2009;24:766\u201371.","journal-title":"J Card Surg"},{"key":"1903_CR9","doi-asserted-by":"crossref","first-page":"H360","DOI":"10.1152\/ajpheart.00630.2006","volume":"292","author":"I Ito","year":"2007","unstructured":"Ito I, Jarajapu YP, Grant MB, Knot HJ. Characteristics of myogenic tone in the rat ophthalmic artery. Am J Physiol Heart Circ Physiol. 2007;292:H360\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1903_CR10","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1476-5381.2011.01307.x","volume":"163","author":"Z Bagi","year":"2011","unstructured":"Bagi Z, Feher A, Cassuto J, Akula K, Labinskyy N, Kaley G, Koller A. Increased availability of angiotensin AT1 receptors leads to sustained arterial constriction to angiotensin II in diabetes\u2014role for Rho-kinase activation. Br J Pharmacol. 2011;163:1059\u201368.","journal-title":"Br J Pharmacol"},{"key":"1903_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1161\/01.CIR.0000020682.73694.AB","volume":"106","author":"M Takemoto","year":"2002","unstructured":"Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediated hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002;106:57\u201362.","journal-title":"Circulation"},{"key":"1903_CR12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/ANA.0b013e3181cd318b","volume":"22","author":"T Ishiyama","year":"2010","unstructured":"Ishiyama T, Shibuya K, Ichikawa M, Masamune T, Kiuchi R, Sessler DI, Matsukawa T. Cerebral pial vascular changes under propofol or sevoflurane anesthesia during global cerebral ischemia and reperfusion in rabbits. J Neurosurg Anesthesiol. 2010;22:207\u201313.","journal-title":"J Neurosurg Anesthesiol"},{"key":"1903_CR13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/372231a0","volume":"372","author":"AP Somlyo","year":"1994","unstructured":"Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature (Lond). 1994;372:231\u20136.","journal-title":"Nature (Lond)"},{"key":"1903_CR14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1096\/fasebj.1.3.2887477","volume":"1","author":"JA Bevan","year":"1987","unstructured":"Bevan JA, Duckworth J, Laher I, Oriowo MA, McPherson GA, Bevan RD. Sympathetic control of cerebral arteries: specialization in receptor type, reserve, affinity, and distribution. FASEB J. 1987;1:193\u20138.","journal-title":"FASEB J"},{"key":"1903_CR15","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1213\/01.ANE.0000147510.25610.9C","volume":"100","author":"R Hartl","year":"2005","unstructured":"Hartl R, Joshi S, Levine S, Wang M, Sciacca RR. Pial arterial response to topical verapamil in acute closed cranial windows in rabbits. Anesth Analg. 2005;100:1140\u20136.","journal-title":"Anesth Analg"},{"key":"1903_CR16","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","volume":"25","author":"H Shimokawa","year":"2005","unstructured":"Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 2005;25:1767\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1903_CR17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","volume":"105","author":"A Masumoto","year":"2002","unstructured":"Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 2002;105:1545\u20137.","journal-title":"Circulation"},{"key":"1903_CR18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.fjc.0000134775.76636.3f","volume":"44","author":"K Inokuchi","year":"2004","unstructured":"Inokuchi K, Ito A, Fukumoto Y, Matoba T, Shiose A, Nishida T, Masuda M, Morita S, Shimokawa H. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery. J Cardiovasc Pharmacol. 2004;44:275\u20137.","journal-title":"J Cardiovasc Pharmacol"},{"key":"1903_CR19","doi-asserted-by":"crossref","first-page":"H1744","DOI":"10.1152\/ajpheart.2000.278.6.H1744","volume":"278","author":"Y Eto","year":"2000","unstructured":"Eto Y, Shimokawa H, Hiroki J, Morishige K, Kandabashi T, Matsumoto Y, Amano M, Hoshijima M, Kaibuchi K, Takeshita A. Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am J Physiol Heart Circ Physiol. 2000;278:H1744\u201350.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1903_CR20","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/01.ATV.21.4.548","volume":"21","author":"K Morishige","year":"2001","unstructured":"Morishige K, Shimokawa H, Eto Y, Kandabashi T, Miyata K, Matsumoto Y, Kaibuchi K, Takeshita A. Adenovirus-mediated transfer of dominant-negative rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol. 2001;21:548\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1903_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0008-6363(01)00291-7","volume":"51","author":"H Shimokawa","year":"2001","unstructured":"Shimokawa H, Morishige K, Miyata K, Kandabashi T, Eto Y, Ikegaki I, Asao T, Kaibuchi K, Takeshita A. Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res. 2001;51:169\u201377.","journal-title":"Cardiovasc Res"},{"key":"1903_CR22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/40187","volume":"389","author":"M Uehata","year":"1997","unstructured":"Uehata M, Ishizaki T, Satoh H, Ono T, Yamagami K, Inui J, Maekawa M, Narumiya S. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond). 1997;389:990\u20134.","journal-title":"Nature (Lond)"},{"key":"1903_CR23","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/hy1201.096541","volume":"38","author":"A Masumoto","year":"2001","unstructured":"Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A. Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension. 2001;38:1307\u201310.","journal-title":"Hypertension"},{"key":"1903_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","volume":"94","author":"K Abe","year":"2004","unstructured":"Abe K, Shimokawa H, Morikawa K, Uwatoku T, Oi K, Matsumoto Y, Hattori T, Nakashima Y, Kaibuchi K, Sueishi K, Takeshita A. Long-term treatment with a rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats. Circ Res. 2004;94:385\u201393.","journal-title":"Circ Res"},{"key":"1903_CR25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1164\/rccm.200405-637OC","volume":"171","author":"T Nagaoka","year":"2005","unstructured":"Nagaoka T, Fagan KA, Gebb SA, Morris KG, Suzuki T, Shimokawa H, McMurtry IF, Oka M. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med. 2005;171:494\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1903_CR26","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.2003.029470","volume":"91","author":"Y Fukumoto","year":"2005","unstructured":"Fukumoto Y, Matoba T, Ito A, Tanaka H, Kishi T, Hayashidani S, Abe K, Takeshita A, Shimokawa H. Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart. 2005;91:391\u20132.","journal-title":"Heart"},{"key":"1903_CR27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.neuro.2009.12.010","volume":"31","author":"SE James","year":"2010","unstructured":"James SE, Dunham M, Carrion-Jones M, Murashov A, Lu Q. Rho kinase inhibitor Y-27632 facilitates recovery from experimental peripheral neuropathy induced by anti-cancer drug cisplatin. Neurotoxicology. 2010;31:188\u201394.","journal-title":"Neurotoxicology"},{"key":"1903_CR28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12015-009-9107-8","volume":"6","author":"K Gauthaman","year":"2010","unstructured":"Gauthaman K, Fong CY, Bongso A. Effect of ROCK inhibitor Y-27632 on normal and variant human embryonic stem cells (hESCs) in vitro: its benefits in hESC expansion. Stem Cell Rev. 2010;6:86\u201395.","journal-title":"Stem Cell Rev"},{"key":"1903_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejphar.2010.09.007","volume":"648","author":"T Minase","year":"2010","unstructured":"Minase T, Ishima T, Itoh K, Hashimoto K. Potentiation of nerve growth factor-induced neurite outgrowth by the ROCK inhibitor Y-27632: a possible role of IP receptors. Eur J Pharmacol. 2010;648:67\u201373.","journal-title":"Eur J Pharmacol"},{"key":"1903_CR30","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0024-3205(01)01229-2","volume":"69","author":"S Satoh","year":"2001","unstructured":"Satoh S, Utsunomiya T, Tsurui K, Kobayashi T, Ikegaki I, Sasaki Y, Asano T. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage. Life Sci. 2001;69:1441\u201353.","journal-title":"Life Sci"},{"key":"1903_CR31","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/01.STR.31.9.2245","volume":"31","author":"Y Toshima","year":"2000","unstructured":"Toshima Y, Satoh S, Ikegaki I, Asano T. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor. Stroke. 2000;31:2245\u201350.","journal-title":"Stroke"},{"key":"1903_CR32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(00)00504-5","volume":"406","author":"K Iizuka","year":"2000","unstructured":"Iizuka K, Shimizu Y, Tsukagoshi H, Yoshii A, Harada T, Dobashi K, Murozono T, Nakazawa T, Mori M. Evaluation of Y-27632, a rho-kinase inhibitor, as a bronchodilator in guinea pigs. Eur J Pharmacol. 2000;406:273\u20139.","journal-title":"Eur J Pharmacol"},{"key":"1903_CR33","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1001\/archopht.119.8.1171","volume":"119","author":"M Honjo","year":"2001","unstructured":"Honjo M, Inatani M, Kido N, Sawamura T, Yue BY, Honda Y, Tanihara H. Effects of protein kinase inhibitor, HA1077, on intraocular pressure and outflow facility in rabbit eyes. Arch Ophthalmol. 2001;119:1171\u20138.","journal-title":"Arch Ophthalmol"},{"key":"1903_CR34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/5587","volume":"5","author":"K Ito","year":"1999","unstructured":"Ito K, Yoshioka K, Akedo H, Uehata M, Ishizaki T, Narumiya S. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med. 1999;5:221\u20135.","journal-title":"Nat Med"},{"key":"1903_CR35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1096\/fj.05-4197fje","volume":"20","author":"T Kanda","year":"2006","unstructured":"Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K, Takamatsu I, Suano N, Hayashi K, Saruta T. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J. 2006;20:169\u201371.","journal-title":"FASEB J"},{"key":"1903_CR36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/bbrc.2001.5597","volume":"287","author":"K Ohnaka","year":"2001","unstructured":"Ohnaka K, Shimoda S, Nawata H, Shimokawa H, Kaibuchi K, Iwamoto Y, Takayanagi R. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biophys Biochem Res Commun. 2001;287:337\u201342.","journal-title":"Biophys Biochem Res Commun"}],"container-title":["Journal of Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-014-1903-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00540-014-1903-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00540-014-1903-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T02:58:51Z","timestamp":1565751531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00540-014-1903-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,24]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s00540-014-1903-x","relation":{},"ISSN":["0913-8668","1438-8359"],"issn-type":[{"value":"0913-8668","type":"print"},{"value":"1438-8359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,24]]}}}